Search

everythinglearnresearchcommunity

for

Search:↓

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Blocking RANK signaling might help treat metastatic melanoma, but more research is needed.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Chemotherapy often causes hair loss in cancer patients, affecting their mental health, but scalp cooling can help prevent it.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Hashimoto thyroiditis is an autoimmune disease that can lead to an underactive thyroid and is treated with medication and sometimes diet changes or surgery.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Autophagy helps keep skin healthy and may improve treatments for skin diseases.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Apremilast may help treat hair loss in alopecia areata.

Volatile organic compounds can cause inflammation and increase the risk of autoimmune diseases.

Scalp melanoma, a deadly skin cancer, is often found late due to its hard-to-see location, especially in older men. Early detection, possible treatments, and the role of hairdressers in spotting it early are discussed. More research is needed to improve detection and treatment.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

The document concludes that the immune-inhibitory environment of the hair follicle may prevent melanoma development.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.